These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis.
    Author: Bevis T, Ratnakaram R, Smith MF, Bhatti MT.
    Journal: Clin Exp Ophthalmol; 2005 Aug; 33(4):437-9. PubMed ID: 16033370.
    Abstract:
    Giant cell arteritis (GCA) can be a devastating disease resulting in blindness if not promptly diagnosed and treated. The only proven treatment for GCA is systemic corticosteroids; however, there are many side-effects associated with this therapy including ocular side-effects such as ocular hypertension, cataract formation and central serous chorioretinopathy. To raise physician awareness, a patient with biopsy-proven GCA is reported who lost vision during corticosteroid therapy because of central serous chorioretinopathy.
    [Abstract] [Full Text] [Related] [New Search]